Public disclosures

MOLINA ARTURO MD

Company insiders · Chief Medical Officer · Protagonist Therapeutics, Inc

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-17.Following & alerts
Reported transaction lines
1
Buy lines
0
Sell lines
1

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-111

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
MOLINA ARTURO MD

Chief Medical Officer · Protagonist Therapeutics, Inc

PTGX

Protagonist Therapeutics, Inc

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 81397 · SEC code covers open-market or private transactions · Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.

2026-11-162026-11-17

≈ $338,798.70

2,718 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement